HAO: financial statements from SEC — TradeAlmanac

HAO

Haoxi Health Technology Limited - Class A Ord Share: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	30 Jun 2025	30 Jun 2024	30 Jun 2023	30 Jun 2022
Revenue	33M	49M	28M	16M
Cost of revenue	32M	46M	26M	16M
Gross profit	927,750	3M	2M	648,721
Research and development	79,544	79,985	58,161	102,524
Selling, general and administrative	3M	911,531	775,961	239,941
Operating expenses	3M	1M	866,255	379,953
Operating income	−2M	2M	1M	268,768
Pre-tax income	4M	2M	1M	259,595
Income tax	270,744	443,582	220,653	15,008
Net income	4M	1M	969,752	244,587
Earnings per share	1.66	1.06	0.87	0.01
Earnings per share, diluted	1.32	1.06	0.87	0.01
Weighted average shares	2M	1M	1M	25M
Weighted average shares, diluted	2M	1M	1M	25M

Balance sheet

Metric	18 Aug 2026	30 Jun 2025	30 Jun 2024	30 Jun 2023	30 Jun 2022	30 Jun 2021
Cash and equivalents	—	9M	7M	1M	293,511	55,886
Receivables	—	460,272	226,747	7,748	—

Cash flow

Metric	30 Jun 2025	30 Jun 2024	30 Jun 2023	30 Jun 2022
Operating cash flow	−3M	−747,576	−872,132	−675,361
Depreciation and amortisation	294,611	10,567	8,393	2,212
Share-based compensation	58,602	—	—

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator